Switzerland
# |
Name |
Price to Earnings Ratio (P/E) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
1,529.53 |
Feb. 3, 2025 | USD 13.36 | -0.81% |
|
Switzerland |
|
2 |
1,378.51 |
Feb. 3, 2025 | USD 74.55 | -2.22% |
|
Switzerland |
|
3 |
263.41 |
Feb. 3, 2025 | USD 46.21 | -3.47% |
|
Switzerland |
|
4 |
75.78 |
Feb. 3, 2025 | USD 138.90 | -2.86% |
|
Switzerland |
|
5 |
67.07 |
Feb. 3, 2025 | USD 651.30 | 2.02% |
|
Switzerland |
|
6 |
60.11 |
Feb. 3, 2025 | USD 382.54 | -3.00% |
|
Switzerland |
|
7 |
48.17 |
Feb. 3, 2025 | USD 126.21 | -1.33% |
|
Switzerland |
|
8 |
42.73 |
Feb. 3, 2025 | USD 43.76 | -1.99% |
|
Switzerland |
|
9 |
36.45 |
Feb. 3, 2025 | USD 1.12 K | -0.26% |
|
Switzerland |
|
10 |
35.24 |
Feb. 3, 2025 | USD 62.45 | -2.60% |
|
Switzerland |
|
11 |
25.33 |
Feb. 3, 2025 | USD 60.16 | -1.72% |
|
Switzerland |
|
12 |
21.52 |
Feb. 3, 2025 | USD 161.30 | -1.97% |
|
Switzerland |
|
13 |
21.51 |
Feb. 3, 2025 | USD 88.99 | -0.28% |
|
Switzerland |
|
14 |
20.48 |
Feb. 3, 2025 | USD 250.45 | -3.26% |
|
Switzerland |
|
15 |
19.44 |
Feb. 3, 2025 | USD 1.14 K | -1.12% |
|
Switzerland |
|
16 |
18.50 |
Feb. 3, 2025 | USD 333.72 | 0.27% |
|
Switzerland |
|
17 |
17.32 |
Feb. 3, 2025 | USD 104.72 | -0.12% |
|
Switzerland |
|
18 |
6.21 |
Feb. 3, 2025 | USD 3.57 | -5.82% |
|
Switzerland |
|
19 |
3.33 |
Feb. 3, 2025 | USD 17.87 | -4.83% |
|
Switzerland |
|
20 |
1.93 |
Feb. 3, 2025 | USD 21.72 | -0.35% |
|
Switzerland |
|
21 |
-2.52 |
Feb. 3, 2025 | USD 5.05 | -4.17% |
|
Switzerland |
|
22 |
-15.89 |
Feb. 3, 2025 | USD 27.36 | -2.78% |
|
Switzerland |
|
23 |
-27.99 |
Feb. 3, 2025 | USD 15.53 | -0.65% |
|
Switzerland |
|
24 |
-56.25 |
Feb. 3, 2025 | USD 24.30 | -3.46% |
|
Switzerland |
The Healthcare company in Switzerland with the highest Price to Earnings Ratio (P/E) is medmix AG (Swiss Stock Exchange: MEDX.SW) at 1,529.53.
The Healthcare company in Switzerland with the lowest Price to Earnings Ratio (P/E) is Kuros Biosciences AG (Swiss Stock Exchange: KURN.SW) at -56.25.
The top 10 Healthcare companies in Switzerland by Price to Earnings Ratio (P/E) are medmix AG, Medartis Holding AG, Sandoz Group AG, Straumann Holding AG, Lonza Group AG, Ypsomed Holding AG, Medacta Group SA, Basilea Pharmaceutica AG, Siegfried Holding AG and Bachem Holding AG.
The bottom 10 Healthcare companies in Switzerland by Price to Earnings Ratio (P/E) are Kuros Biosciences AG, Aevis Victoria SA, PolyPeptide Group AG, Molecular Partners AG, DocMorris AG, Santhera Pharmaceuticals Holding AG, Ascom Holding AG, Novartis AG, Roche Holding AG and Metall Zug AG.